We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaillie Gifford Regulatory News (USA)

Share Price Information for Baillie Gifford (USA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 193.00
Bid: 192.40
Ask: 192.60
Change: -2.20 (-1.13%)
Spread: 0.20 (0.104%)
Open: 192.20
High: 193.40
Low: 192.20
Prev. Close: 195.20
USA Live PriceLast checked at -
Baillie Gifford US Growth is an Investment Trust

To produce long-term capital growth by investing in US companies which have the potential to grow substantially faster than the average company over the long term.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison update on Baillie Gifford US Growth Trust

4 Oct 2022 13:10

RNS Number : 7468B
Baillie Gifford US Growth Trust PLC
04 October 2022
 

London, UK, 4 October 2022

 

Edison issues update on Baillie Gifford US Growth Trust (USA)

Baillie Gifford US Growth Trust (USA) has seen its net asset value (NAV) significantly fall in 2022 as growth stocks have fallen out of favour with investors. In addition, USA's share price has moved to a material discount to NAV for the first time since launch in March 2018. As a long-term fundamental investor, Baillie Gifford believes that the current investment opportunities in long-duration, high-growth stocks provide a tremendous opportunity for conviction investors, which could lay the foundations for the long-term outperformance of the fund.

 

Baillie Gifford is well known for its growth investment style; however, the US team arguably take this further than almost any other team. Its relentless focus on identifying tomorrow's leaders, often at a very early stage of their development in nascent and dramatically evolving markets within what is possibly the most prominent growth market in the world, sets it apart from the majority of its peers. In addition, the material weighting towards unquoted investments adds a further layer of differentiation. In 2022, growth as a style has fallen dramatically out of favour, which has negatively affected USA investor returns in both NAV and share price terms. However, the collegiate management team and long-term process have been in place over many years, over which time investors have been well rewarded. There are clearly risks in owning in some cases pre-profit and unquoted investments, which may guide investors to consider the position size for investments of this nature within diversified portfolios. The current discount to NAV of 19% could prove to be an attractive level to add to or initiate positions in USA.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

David Holder +44 (0)77 9626 8072 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABDBDGSGGDGDS
Date   Source Headline
19th Apr 20244:57 pmRNSTransaction in Own Shares
19th Apr 202412:41 pmRNSNet Asset Value(s)
18th Apr 20243:54 pmRNSHolding(s) in Company
18th Apr 202411:36 amRNSNet Asset Value(s)
17th Apr 202412:07 pmRNSNet Asset Value(s)
16th Apr 20244:02 pmRNSNet Asset Value(s)
15th Apr 202411:27 amRNSNet Asset Value(s)
12th Apr 20245:08 pmRNSTransaction in Own Shares
12th Apr 202411:52 amRNSNet Asset Value(s)
11th Apr 202411:19 amRNSNet Asset Value(s)
10th Apr 202412:46 pmRNSNet Asset Value(s)
9th Apr 202411:28 amRNSNet Asset Value(s)
8th Apr 202411:34 amRNSNet Asset Value(s)
5th Apr 202411:19 amRNSNet Asset Value(s)
4th Apr 202412:20 pmRNSNet Asset Value(s)
3rd Apr 202411:23 amRNSNet Asset Value(s)
2nd Apr 20244:35 pmRNSNet Asset Value(s)
2nd Apr 20243:54 pmRNSNet Asset Value(s)
2nd Apr 20241:35 pmRNSNet Asset Value(s)
2nd Apr 202411:52 amRNSTotal Voting Rights
28th Mar 202412:11 pmRNSNet Asset Value(s)
27th Mar 202412:05 pmRNSNet Asset Value(s)
26th Mar 20244:57 pmRNSTransaction in Own Shares
26th Mar 202412:05 pmRNSNet Asset Value(s)
25th Mar 202412:29 pmRNSNet Asset Value(s)
25th Mar 202411:56 amRNSBlock listing Interim Review
22nd Mar 202412:09 pmRNSNet Asset Value(s)
21st Mar 202412:05 pmRNSNet Asset Value(s)
20th Mar 20245:26 pmRNSTransaction in Own Shares
20th Mar 202412:03 pmRNSNet Asset Value(s)
19th Mar 202411:52 amRNSNet Asset Value(s)
18th Mar 20245:16 pmRNSTransaction in Own Shares
18th Mar 202411:35 amRNSNet Asset Value(s)
15th Mar 202411:21 amRNSNet Asset Value(s)
14th Mar 202411:01 amRNSNet Asset Value(s)
13th Mar 202411:48 amRNSNet Asset Value(s)
12th Mar 202411:30 amRNSNet Asset Value(s)
11th Mar 202411:09 amRNSNet Asset Value(s)
8th Mar 202412:23 pmRNSNet Asset Value(s)
7th Mar 202411:33 amRNSNet Asset Value(s)
6th Mar 20241:32 pmRNSNet Asset Value(s)
5th Mar 202412:33 pmRNSNet Asset Value(s)
4th Mar 202412:05 pmRNSNet Asset Value(s)
1st Mar 20242:03 pmRNSNet Asset Value(s)
1st Mar 202411:08 amRNSTotal Voting Rights
29th Feb 20241:27 pmRNSNet Asset Value(s)
28th Feb 202411:23 amRNSNet Asset Value(s)
27th Feb 20244:33 pmRNSHolding(s) in Company
27th Feb 202411:42 amRNSNet Asset Value(s)
26th Feb 202411:40 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.